Brief: Fresenius Sees FY26 EBIT Margin Above 11.5%
Yesterday 05:50
BRIEF-Fresenius Sees FY26 EBIT Margin Above 11.5% Nov 4 (Reuters) - FRESENIUS SE FREn.DE:
Q3 REVENUE BEFORE SPECIAL ITEMS AT EUR 5.80 BILLION VERSUS CONSENSUS OF 5.79 BILLION
Q3 EBIT BEFORE SPECIAL ITEMS AT EUR 638 MILLION VERSUS CONSENSUS OF 619 MILLION
Q3 CORE NET INCOME BEFORE SPECIAL ITEMS AT EUR 403 MILLION
FY 2026 CONSTANT-CURRENCY CORE EPS GROWTH NOW EXPECTED IN UPPER HALF OF 10%-15% RANGE
FY 2026 EBIT MARGIN NOW EXPECTED ABOVE 11.5%, PREVIOUSLY AROUND 11.5%
Further company coverage: [FREn.DE]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785269;))
Recent news on Fresenius SE & Co. KGaA
See all newsFresenius lifts 2026 expectations after strong Q3 (updated)
Healthcare firm Fresenius Q3 revenue rises on Kabi growth; lifts outlook
Brief: Fresenius Sees FY26 EBIT Margin Above 11.5%
Brief: Fresenius SE Q3 Revenue EUR 5,803 Million
Fresenius signs biosimilars pipeline agreement with WuXi Biologics (updated)